Carl J Pepine Selected Research

Catheters

1/2021	The role of a comprehensive two-step diagnostic evaluation to unravel the pathophysiology of MINOCA: A review.
1/2021	Clinical Safety Profile of Transendocardial Catheter Injection Systems: A Plea for Uniform Reporting.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carl J Pepine Research Topics

Disease

81	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 05/2002
65	Hypertension (High Blood Pressure) 01/2022 - 02/2003
58	Myocardial Infarction 01/2022 - 08/2002
50	Ischemia 10/2022 - 06/2002
39	Heart Failure 01/2022 - 04/2003
35	Stroke (Strokes) 01/2022 - 02/2004
32	Cardiovascular Diseases (Cardiovascular Disease) 03/2021 - 10/2007
23	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021 - 08/2002
12	Chest Pain (Chest Pains) 04/2020 - 06/2002
10	Inflammation (Inflammations) 01/2022 - 02/2004
10	Atherosclerosis 01/2021 - 02/2003
9	Coronary Disease (Coronary Heart Disease) 01/2022 - 11/2005
8	Dyslipidemias (Dyslipidemia) 01/2020 - 02/2004
8	Acute Coronary Syndrome 11/2016 - 02/2003
7	Cardiomyopathies (Cardiomyopathy) 01/2022 - 01/2016
7	ST Elevation Myocardial Infarction 01/2018 - 02/2003
6	Left Ventricular Dysfunction 01/2021 - 02/2010
5	Hemorrhage 11/2021 - 10/2003
5	Infarction (Infarctions) 01/2021 - 05/2002
4	Stable Angina 10/2022 - 02/2003
4	COVID-19 01/2022 - 01/2020
4	Cicatrix (Scar) 01/2021 - 11/2012
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 02/2004
4	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2019 - 10/2004
3	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 01/2018
3	Thrombosis (Thrombus) 11/2021 - 01/2010
3	Rupture 11/2020 - 02/2003
3	Atherosclerotic Plaque (Atheroma) 11/2020 - 02/2004
3	Diabetes Mellitus 01/2020 - 10/2006
3	Angina Pectoris 08/2019 - 08/2008
3	Transient Ischemic Attack 02/2015 - 10/2006
3	Unstable Angina 02/2015 - 08/2002
3	Obesity 09/2013 - 09/2004
2	Myocarditis (Carditis) 01/2022 - 03/2021
2	Edema (Dropsy) 01/2022 - 02/2003
2	Type 2 Diabetes Mellitus (MODY) 11/2021 - 01/2020
2	Kidney Diseases (Kidney Disease) 01/2021 - 10/2005
2	Cardiotoxicity 01/2021 - 01/2018
2	Neuroinflammatory Diseases 01/2020 - 01/2019
2	Microvascular Angina (Cardiac Syndrome X) 01/2020 - 01/2020
2	Frailty 08/2019 - 09/2017

Drug/Important Bio-Agent (IBA)

43	Verapamil (Calan)FDA LinkGeneric 01/2021 - 10/2004
40	trandolapril (Mavik)FDA LinkGeneric 01/2021 - 12/2003
25	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 12/2003
21	Atenolol (Tenormin)FDA LinkGeneric 01/2016 - 01/2004
15	omega-Chloroacetophenone (Mace)IBA 01/2022 - 06/2012
14	Adenosine (Adenocard)FDA LinkGeneric 01/2020 - 04/2003
10	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2009
9	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2022 - 01/2007
9	Hormones (Hormone)IBA 01/2018 - 12/2002
8	Pharmaceutical PreparationsIBA 01/2022 - 11/2005
8	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2021 - 10/2005
8	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2021 - 02/2004
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2020 - 12/2002
8	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 08/2014 - 12/2003
7	LipidsIBA 01/2022 - 06/2002
7	CalciumIBA 11/2021 - 12/2003
6	Estrogens (Estrogen)FDA Link 01/2019 - 09/2004
5	Ranolazine FDA Link 01/2021 - 01/2004
5	Nitroglycerin (Dynamite)FDA LinkGeneric 04/2020 - 01/2004
5	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2020 - 02/2004
5	Triglycerides (Triacylglycerol)IBA 12/2017 - 06/2006
5	C-Reactive ProteinIBA 01/2017 - 02/2004
5	HDL CholesterolIBA 03/2011 - 02/2004
4	Angiotensin Receptor AntagonistsIBA 11/2021 - 10/2005
4	Proteins (Proteins, Gene)FDA Link 11/2021 - 10/2005
4	Minocycline (Cyclops)FDA LinkGeneric 10/2021 - 06/2015
4	DiureticsIBA 01/2021 - 08/2008
4	CreatinineIBA 01/2021 - 06/2002
4	CholesterolIBA 09/2013 - 12/2002
4	fenofibric acid FDA Link 03/2011 - 01/2009
4	LDL CholesterolIBA 03/2011 - 06/2006
3	Angiotensin-Converting Enzyme 2IBA 01/2021 - 10/2013
3	Phytoestrogens (Phytoestrogen)IBA 01/2021 - 06/2006
3	GenisteinIBA 01/2021 - 06/2006
3	ThiazidesIBA 01/2021 - 01/2020
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 12/2015
3	Angiotensin IIIBA 01/2019 - 01/2010
3	Phenobarbital (Luminal)FDA Link 08/2018 - 08/2006
3	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2017 - 02/2004
3	EnzymesIBA 08/2011 - 02/2003
3	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 05/2007 - 02/2006
2	Vasodilator Agents (Vasodilators)IBA 01/2022 - 02/2003
2	1,4-dihydropyridine (dihydropyridine)IBA 01/2022 - 10/2005
2	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 11/2021 - 01/2021
2	AnticoagulantsIBA 11/2021 - 01/2010
2	Lipoproteins (Lipoprotein)IBA 01/2021 - 06/2006
2	daidzeinIBA 01/2021 - 06/2006
2	AnthracyclinesIBA 11/2020 - 01/2018
2	pro-brain natriuretic peptide (1-76)IBA 01/2020 - 01/2018

Therapy/Procedure

61	Therapeutics 10/2022 - 05/2002
21	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022 - 01/2010
8	Percutaneous Coronary Intervention 12/2019 - 10/2003
7	Drug Therapy (Chemotherapy) 01/2022 - 11/2004
3	Injections 10/2016 - 04/2012
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 10/2004 - 05/2002
2	Catheters 01/2021 - 01/2021
2	Ligation 01/2021 - 01/2019
2	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2019 - 06/2010
2	Secondary Prevention 01/2019 - 01/2010